News Announcement

Suven Pharmaceuticals: Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

An update in reference to our previous intimation dated July 13 2024 concerning the inspection conducted by the US FDA at the formulation manufacturing facility of Casper Pharma Private Limited Wholly Owned Subsidiary of the Comapny


दूसरी कैटेगरी